Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$7.74 USD
-0.03 (-0.39%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $7.73 -0.01 (-0.13%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Brokerage Reports
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 81 - 100 ( 130 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
KOL is Buzzing for Apitegromab?s Potential in SMA
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Twelve-Month Data Around the Corner, Will It Rock?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Will Top-Line Results Sparkle for TOPAZ
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Merck Miss in NSCLC Leaves Market Up For Grabs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SITC 2020 Abstract Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
The Most Electrifying (Latent) Myostatin mAb in SMA
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SRK-015 Highlighted at CURE SMA: Awaiting Key Ph 2 TOPAZ Readout Q4:20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D